Search hospitals > Ohio > Cleveland
Cleveland Clinic Taussig Cancer Center
Claim this profileCleveland, Ohio 44106
Global Leader in Lymphoma
Global Leader in Leukemia
Conducts research for Brain Tumor
Conducts research for Cancer
Conducts research for Breast Cancer
769 reported clinical trials
45 medical researchers
Summary
Cleveland Clinic Taussig Cancer Center is a medical facility located in Cleveland, Ohio. This center is recognized for care of Lymphoma, Leukemia, Brain Tumor, Cancer, Breast Cancer and other specialties. Cleveland Clinic Taussig Cancer Center is involved with conducting 769 clinical trials across 433 conditions. There are 45 research doctors associated with this hospital, such as David Peereboom, MD, Dale Shepard, Brian Gastman, MD, and Aaron Gerds, MD, MS.Area of expertise
1Lymphoma
Global LeaderStage III
Stage IV
Stage II
2Leukemia
Global LeaderCD22 positive
HLA-A positive
Philadelphia chromosome positive
Top PIs
David Peereboom, MDCleveland Clinic5 years of reported clinical research
Expert in Glioblastoma
Studies Brain Tumor
18 reported clinical trials
30 drugs studied
Dale ShepardCleveland Clinic Foundation7 years of reported clinical research
Studies Cancer
Studies Tumors
14 reported clinical trials
38 drugs studied
Brian Gastman, MDCleveland Clinic3 years of reported clinical research
Studies Melanoma
Studies Cancer
10 reported clinical trials
13 drugs studied
Aaron Gerds, MD, MSCleveland Clinic Foundation5 years of reported clinical research
Studies Myelofibrosis
Studies Primary Myelofibrosis
11 reported clinical trials
17 drugs studied
Clinical Trials running at Cleveland Clinic Taussig Cancer Center
Breast Cancer
Cancer
Brain Tumor
Non-Hodgkin's Lymphoma
Leukemia
Tumors
Acute Myeloid Leukemia
Lymphoma
T-Cell Lymphoma
Prostate Cancer
Giredestrant + Hormone Therapy
for Early-Stage Breast Cancer
This trial is testing giredestrant, a medication given after initial treatment to prevent breast cancer from returning. It focuses on patients with a specific type of early-stage breast cancer that is hormone-driven and at higher risk of recurrence. Giredestrant works by blocking the hormone estrogen from helping cancer cells grow. Giredestrant has shown promise in previous studies.
Recruiting2 awards Phase 311 criteria
CPAP Devices
for Breast and Lung Cancer
Data collection and assessment on patients with left-sided breast cancer or undergoing lung stereotactic body radiation therapy (SBRT) utilizing continuous positive airway pressure (CPAP) devices.
Recruiting1 award N/A5 criteria
Education Program
for Breast Cancer Screening
The purpose of this study is to identify interventions that are designed to better serve women who are homeless, with a specific focus on increasing screening rates and decreasing late stage breast cancer diagnosis among this high-risk understudied community of women. As a result, the study team hopes to influence the broader homeless healthcare initiative
Recruiting1 award N/A3 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Cleveland Clinic Taussig Cancer Center?
Cleveland Clinic Taussig Cancer Center is a medical facility located in Cleveland, Ohio. This center is recognized for care of Lymphoma, Leukemia, Brain Tumor, Cancer, Breast Cancer and other specialties. Cleveland Clinic Taussig Cancer Center is involved with conducting 769 clinical trials across 433 conditions. There are 45 research doctors associated with this hospital, such as David Peereboom, MD, Dale Shepard, Brian Gastman, MD, and Aaron Gerds, MD, MS.
Where is Cleveland Clinic Taussig Cancer Center located?
To reach Cleveland Clinic Taussig Cancer Center, located at 10201 Carnegie Ave, Cleveland, OH 44106, from the south, take I-77 or I-71 North to downtown Cleveland. Then, take I-90 East to the Chester Ave. exit and turn right. For real-time driving directions based on live traffic updates, consider using Waze.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance inquiries at Cleveland Clinic Taussig Cancer Center, contact the Patient Financial Advocates at 216.442.1600 or toll-free at 855.831.1284. They offer assistance with insurance coverage, cost estimates, and financial assistance programs. Uninsured or self-paying patients are entitled to a good faith estimate for scheduled services.
What insurance does Cleveland Clinic Taussig Cancer Center accept?
The Cleveland Clinic Taussig Cancer Center accepts a wide range of insurance and managed care plans, including but not limited to:
- **Major Insurance Plans**: Network Blue, PPC, Traditional, Humana, MultiPlan Network, United Healthcare.
- **Direct-to-Employer Plans**: Cigna Medicare HMO, Florida Blue (BlueMedicare, BlueMedicare Choice), Humana Medicare, United Healthcare - Medicare Solutions.
- **Commercial Plans**: Aetna Health Inc., AvMed Health Plans, BCBS Truli for Health, Cigna Healthcare of Florida Inc., Florida Blue (Blue Select, Health Options).
For specific coverage and plan participation, it's recommended to contact your insurance provider directly. For assistance, call 844.500.9451 to speak with a Patient Financial Advocate (PFA).
What awards or recognition has Cleveland Clinic Taussig Cancer Center received?
Cleveland Clinic's Taussig Cancer Center is internationally recognized for its comprehensive cancer care and research, supported by over 250 healthcare professionals across various disciplines. As part of the NCCN and NCI-designated Case Comprehensive Cancer Center, it provides access to numerous clinical trials and support programs. Since 2017, Cleveland Clinic has invested $12.3 million in internal funding for research Centers of Excellence, including a notable Center of Excellence in Ewing sarcoma, leading to over $71 million in extramural grant funding.